期刊文献+

特发性血小板减少性紫癜患者血小板相关抗体和淋巴细胞亚群的临床观察 被引量:6

Detection of platelet-associated antibody and lymphocyte subsets in patients with idiopathic thrombocytopenic purpura
下载PDF
导出
摘要 目的检测急性特发性血小板减少性紫癜患者血小板相关抗体(PAIg)和淋巴细胞亚群,探讨其在特发性血小板减少性紫癜(ITP)免疫发病机制中的作用及临床意义。方法分别采用酶联免疫吸附法(ELISA)和流式细胞术(FCM)检测20例ITP患者及20例健康人外周血中PAIg和T淋巴细胞表型。结果ITP患者组PAIg明显高于健康人组(P<0.01);ITP患者组CD3+、CD4+、CD4+/CD8+显著低于健康人组(P<0.01),CD8+显著高于健康人组(P<0.01)。结论血小板相关抗体和T淋巴细胞亚群的变化能较好的反映ITP发病的病理机制。 Objective To explore the clinical significance of platelet - associated antibody(PAIg) and T lymphocytes subsets in patients with idiopathic thrombocytopenic purpura (ITP) . Methods PAIgG and T lymphocyte subsets were detected by enzyme linked immunosorbent assay (ELISA) and flow cytometry (FCM), Results PAIg in ITP group was higher than that in normal group( P 〈 0. 01 =. The percentage of CD3^+ , CD4^+ and the value of CD4^+/CD8^+ was lower in ITP patients. The percentage of CD8^+ and CD19^+ was higher. There was significant difference between ITP group and normal group ( P〈 0.01 ). Conclusion PAIg and the changes of T lymphocyte subset can reflect the pathogenesis of ITP.
出处 《临床和实验医学杂志》 2007年第2期28-29,共2页 Journal of Clinical and Experimental Medicine
关键词 特发性血小板减少性紫癜 血小板相关抗体 T淋巴细胞亚群 Idiopathic thrombocytopenic purpura Platelet- associated antibody T lymphocyte subset
  • 相关文献

参考文献6

  • 1McMillan R;Wang L;Tomer A.Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP[J],2004(04).
  • 2Chang M;Nakagawa PA;Williams SA.Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro[J],2003(03).
  • 3高举,罗春华.自身免疫性血小板减少性紫癜的发病机制及诊治进展[J].中国实用儿科杂志,2003,18(2):77-79. 被引量:48
  • 4Haggqvist B;Hultman P.Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response[J],2003(02).
  • 5Cines DB;Blanchette VS.Immune thrombocytopenic purpura[J],2002.
  • 6张之南;沈悌.血液病诊断及疗效标准.,1998.

二级参考文献13

  • 1[1]McMillan R.Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol,2000,37:239
  • 2[2]Beardsley DS, Ertem M. Platelet autoantibodies in immune thrombocytopenic purpura. Transfus Sci,1998,19:237
  • 3[3]Mcfarl J. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev, 2002.16
  • 4[4]Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev,2002,16:9
  • 5[5]Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood,1996,87:4245
  • 6[6]Gernsheimer T. Pathophysiology and thrombokinetics in autoimmune thrombocytopenia. Blood Rev,2002,16:7
  • 7[7]Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Semin Hematol,2000,37:249
  • 8[8]George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood,1996,88:3
  • 9[9]Tarantino MD. Acute immune (idiopathic) thrombocytopenic purpura in children. Blood Rev, 2002,16:19
  • 10[10]Blanchette V.Childhood chronic immune thrombocytopenic purpura (ITP). Blood Rev,2002,16:23

共引文献56

同被引文献62

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部